The Relationship between Nasal Carriage of Staphylococcus aureus and Surgical Site Infections in a Hospital Center in Morocco

Table 3

Antibiotic resistance profile of isolated Staphylococcus aureus strains MRSA and MSSA (N = 38).

Antibiotics	MRSA (n = 14)		MSSA (n = 24)
	Sensitive	Resistant	Sensitive	Resistant
Amikacin (AK)	14 (100%)	—	24 (100%)	—
Amoxicillin + clavulanic acid (AMC)	6 (42.85%)	8 (57.14%)	20 (83.33%)	4 (16.67%)
Amoxicillin (AX)	5 (35.71%))	9 (64.29%)	21 (87.50%)	3 (12.50%)
Chloramphenicol (C)	14 (100%)	—	24 (100%)	—
Ceftazidime (CAZ)	2 (14.28%)	12 (85.72%)	15 (62.50%)	9 (37.50%)
Cefixime (CFM)	3 (21.42%)	11 (78.58%)	16 (66.67%)	8 (33.33%)
Ciprofloxacin (CIP)	14 (100%)	—	24 (100%)	—
Cefalexin (CN)	14 (100%)	—	24 (100%)	—
Ceftriaxone (CRO)	6 (42.85%)	8 (57.15%)	19 (79.17%)	5 (20.83%)
Cefotetan (CT)	12 (85.71%)	2 (14.29%)	24 (100%)	—
Cefotaxime (CTX)	—	14 (100%)	18 (75.00%)	6 (25.00%)
Erythromycin (E)	5 (35.71%)	9 (64.29%)	22 (91.67%)	2 (08.33%)
Fusidic acid (F)	11 (78.57%)	3 (21.43%)	24 (100%)	—
Cefoxitin (FOX)	—	14 (100%)	19 (79.17%)	5 (20.83%)
Imipenem (IPM)	14 (100%)	—	24 (100%)	—
Cephalotine (KF)	2 (14.28%)	12 (85.72%)	14 (58.34%)	10 (41.66%)
Lincomycin (L)	14 (100%)	—	24 (100%)	—
Nalidixic acid (NA)	6 (42.85%)	08 (57.15%)	22 (91.67%)	2 (08.33%)
Ofloxacin (OFX)	14 (100%)	—	24 (100%)	—
Oxacillin (OX)	1 (07.14%)	13 (92.86%)	24 (100%)	—
Piperacillin (PRL)	3 (21.42%)	11 (78.58%)	20 (83.34%)	04 (16.66%)
Rifampicin (RA)	14 (100%)	—	24 (100%)	—
Trimethoprim-sulfametoxazole (SXT)	14 (100%)	—	24 (100%)	—
Tetracycline (TE)	14 (100%)	0—	24 (100%)	—
Tobramycin (TOB)	12 (85.71%)	2 (14.29%)	24 (100%)	—
Ticarcillin (TIC)	—	14(100%)	20 (83.34%)	4 (16.66%)
Teicoplanin (TEC)	4 (28.57%)	12 (85.73%)	21 (87.50%	3 (12.50%)